Intrexon Corporation (XON) Shares are Down -3.02%

Intrexon Corporation (XON) : During the past 4 weeks, traders have been relatively bearish on Intrexon Corporation (XON), hence the stock is down -11.66% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -3.51% relative to the S&P 500. The 4-week change in the price of the stock is -11.77% and the stock has fallen -3.02% in the past 1 week.

The stock has recorded a 20-day Moving Average of 8.16% and the 50-Day Moving Average is 3.37%.The 200 Day SMA reached 14.92%. Intrexon Corporation has dropped 14.71% during the last 3-month period . Year-to-Date the stock performance stands at -15.99%.


Intrexon Corporation (NYSE:XON): After opening at $25.38, the stock dipped to an intraday low of $24.96 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $25.76 and the buying power remained strong till the end. The stock closed at $25.33 for the day, a gain of 0.16% for the day session. The total traded volume was 966,252. The stocks close on the previous trading day was $25.29.

Intrexon Corporation is engaged in the field of synthetic biology. The Company designs, builds and regulates gene programs, which are Deoxyribonucleic Acid (DNA) sequences that consist of genetic components. The Companys synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells. The Companys technologies include UltraVector, RheoSwitch Therapeutic System, Cell Systems Informatics, Protein Engineering, AttSite Recombinases, LEAP (Laser Enabled Analysis and Processing), Antibody Discovery, Neurospora & Agaricus Platforms, Endometrial Regenerative Cells, ActoBiotics, Porcine Research Models and BeyondBio. The Company serves various markets, including health, food, energy, environment and consumer. The Company has five operating divisions: Human Therapeutics, Synthetic Immunology, Animal Sciences, Agricultural Biotech, and Industrial Products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.